Aspiring to Reasonableness in Accelerated Approval: Anticipating and Avoiding the Next Aducanumab
Year: 2022
Type: article
Source: Drugs & Aging
Institutions: University of Pennsylvania, George Mason University
Language: English
Subfield: Physiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: UNDERSTANDING HOW THE STUDY PARTNER REQUIREMENT IMPACTS THE DISCOVERY AND TRANSLATION OF PRECLINICAL ALZHEIMERS DISEASE, Alzheimer's Disease Core Center, Caregivers' Experiences with and Perspectives on Communication with Persons with Dementia, Penn Alzheimer's Disease Research Center (ADRC)
OpenAlex ID: W4282570265